Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Ibrutinib plus Bendamustine and Rituximab in Untreated Mantle-Cell Lymphoma.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Ibrutinib plus Bendamustine and Rituximab in Untreated Mantle-Cell Lymphoma.
Ibrutinib plus Bendamustine and Rituximab in Untreated Mantle-Cell Lymphoma. N Engl J Med. 2022 06 30; 386(26):2482-2494.
View in:
PubMed
subject areas
Adenine
Aged
Antineoplastic Combined Chemotherapy Protocols
Bendamustine Hydrochloride
Disease Progression
Humans
Lymphoma, Mantle-Cell
Maintenance Chemotherapy
Piperidines
Protein Kinase Inhibitors
Pyrazoles
Pyrimidines
Remission Induction
Rituximab
Survival Analysis
authors with profiles
Yuko Mishima